AI
FLACW

Arena Investors’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Arena Investors’s Portfolio FLACW Stock Details FLACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-37,138
Closed -$31.4K – 135
2022
Q3 		$31.4K Hold
37,138
– – 0.01% 109
2022
Q2 		$3K Buy
+37,138
New +$6.45K ﹤0.01% 161

Arena Investors's FLACW Position: Q4 2022 in Review

Arena Investors sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 37,138 shares — an estimated $31.4K sold.

Arena Investors first reported a position in FLACW in Q2 2022 and held it in 2 quarters. The position peaked at $31.4K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

  • Arena Investors reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
  • Arena Investors sold 37,138 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $31.4K.
  • Arena Investors first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2022 and held it in 2 quarters.
  • Arena Investors's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $31.4K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Arena Investors's 13F filing for Q4 2022, filed 14 Feb 2023.